KPV
Alpha-MSH-derived tripeptide — potent anti-inflammatory for gut health, IBD, and skin conditions.
Category
Healing & Recovery
Frequency
1–2x daily
Research
Preclinical + Phase 2What is KPV?
KPV is a tripeptide (Lysine-Proline-Valine) derived from the C-terminal of Alpha-Melanocyte-Stimulating Hormone (α-MSH). It contains the core anti-inflammatory activity of α-MSH in a minimal 3 amino acid sequence, making it highly stable, well-tolerated, and capable of oral delivery.
KPV is notable for its extraordinarily potent anti-inflammatory effects, particularly in the gut and skin. Studies have shown it activates melanocortin receptors (specifically MC1-R, MC3-R, and MC5-R) in immune cells, producing a powerful anti-inflammatory response without the side effects of corticosteroids.
KPV is gaining significant attention as a potential treatment for Inflammatory Bowel Disease (IBD), including both Crohn's disease and Ulcerative Colitis. Unlike BPC-157 which heals tissue mechanically, KPV specifically targets the immune-mediated inflammation at the root of IBD.
How It Works
Melanocortin Receptor Activation: KPV activates MC1-R, MC3-R, and MC5-R receptors on immune cells (particularly macrophages and dendritic cells), suppressing the production of pro-inflammatory cytokines.
NF-κB Inhibition: KPV inhibits the NF-κB transcription factor — the master regulator of the inflammatory response — directly in immune and epithelial cells.
Intestinal Epithelial Healing: KPV promotes intestinal epithelial cell recovery and barrier function restoration, complementing its anti-inflammatory action in the gut.
Benefits
- Potent anti-inflammatory for gut (IBD, Crohn's, IBS)
- Skin inflammation reduction (psoriasis, dermatitis, acne)
- Wound healing acceleration
- Can be taken orally for gut effects
- Well-tolerated with excellent safety profile
- Systemic anti-inflammatory via injection
- Complementary with BPC-157 for gut healing stack
Dosing Protocol
| Phase | Dose | Frequency | Duration |
|---|---|---|---|
| Oral (gut) | 500mcg–2mg | Once or twice daily | 4–8 weeks |
| Injectable (systemic) | 200–500mcg | Once daily SC | 4 weeks |
| Topical (skin) | 500mcg in cream base | 2x daily to affected area | As needed |
Always start at the lowest effective dose and titrate up gradually.
Side Effects
Common
- ⚠Generally very well tolerated
- ⚠Mild injection site reaction
- ⚠Mild nausea if oral dose taken without food
Rare
- •Possible skin pigmentation change (melanocortin receptor, theoretical)
Who Should NOT Use KPV
- ✕Active skin cancer (melanocortin receptor activation)
- ✕Pregnancy or breastfeeding
- ✕On immunosuppressive therapy (consult physician)
What to Expect
Many gut users notice reduced bloating and cramping within the first week. Skin users see reduced redness.
Substantial anti-inflammatory effect. IBD symptoms often markedly reduced. Skin conditions clearing.
Sustained remission in many IBD users. Skin completely cleared in most cases.
FAQ
Q: Should I use KPV or BPC-157 for gut issues?
A: They work through different mechanisms and are best combined. BPC-157 heals the physical gut tissue (angiogenesis, growth factors). KPV targets the immune inflammation. Together they address both aspects of inflammatory gut disease.
Q: Does oral KPV work as well as injectable?
A: For gut conditions, oral KPV may actually be superior to injectable because it delivers the peptide directly to the intestinal tissue where it is needed. For systemic inflammatory conditions, injectable is more reliable.
Where to Get KPV in Vietnam
See our community-verified supplier list with COA verification and cold-chain shipping to Vietnam.
View Supply Index